Herba Epimedii water extract elevates estrogen level and improves lipid metabolism in postmenopausal women
Authors:
- 11 August 2008
- journal article
- research article
- Published by Wiley in Phytotherapy Research
- Vol. 22 (9) , 1224-1228
Abstract
Hormone replacement therapy (HRT) can ameliorate lipid metabolism after menopause, but it is not suitable for long‐term use because of serious side effects. Herba Epimedii is a widely used herbal medicine in many Asian countries, it potentially treats menopausal syndrome and its complications with few side effects and good curative effects. The study aimed to evaluate the effects of Herba Epimedii water extract on blood lipid and sex hormone levels. Ninety subjects were randomly divided into two groups: a trial group which received Herba Epimedii water extract and a control group which was administered an equal amount of water placebo. At the baseline and after 6 months of medication, serum estradiol (E2), progesterone (P), testosterone (T), total cholesterol (TC), triglyceride (TG), high density lipoprotein cholesterol (HDL‐C) and low density lipoprotein cholesterol (LDL‐C) concentrations were measured. The results indicated that Herba Epimedii water extract decreased the TC and TG levels (p < 0.01). Furthermore, Herba Epimedii water extract significantly increased the serum level of E2 (p < 0.01) compared with the pre‐treatment level. In conclusion, Herba Epimedii water extract produces its beneficial actions in postmenopausal women. Copyright © 2008 John Wiley & Sons, Ltd.Keywords
Funding Information
- National Basic Research Program of China (National ‘973’ project, 2005CB523301)
This publication has 29 references indexed in Scilit:
- Case-Control Study of Postmenopausal Hormone Replacement Therapy and Endometrial CancerAmerican Journal of Epidemiology, 2006
- Flavonoids derived from herbal Epimedium Brevicornum Maxim prevent OVX-induced osteoporosis in rats independent of its enhancement in intestinal calcium absorptionBone, 2006
- Randomized trial of effects of continuous combined HRT on markers of lipids and coagulation in women with acute coronary syndromes: WHISP Pilot StudyEuropean Heart Journal, 2006
- Why is cardiovascular health important in menopausal women?Climacteric, 2006
- Endometrial Carcinoma Risks among Menopausal Estrogen plus Progestin and Unopposed Estrogen Users in a Cohort of Postmenopausal WomenCancer Epidemiology, Biomarkers & Prevention, 2005
- New Estrogenic Prenylflavone fromEpimedium brevicornumInhibits the Growth of Breast Cancer CellsPlanta Medica, 2005
- Proliferation-stimulating effects of icaritin and desmethylicaritin in MCF-7 cellsEuropean Journal of Pharmacology, 2004
- A pilot study of the effects of phytoestrogen supplementation on postmenopausal endometriumJournal of the Society for Gynecologic Investigation, 2002
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Effects of phytoestrogens on aromatase, 3β and 17β-hydroxysteroid dehydrogenase activities and human breast cancer cellsLife Sciences, 2000